Skip to content
Bomb Report – Lifestyle
Author:
Kibow Therapeutics
Kibow Therapeutics to Present Phase 2b Results for KT-301 in Stage 4 Chronic Kidney Disease at ASN Kidney Week 2026
October 21, 2026